ALPHA TEKNOVA, INC. Increase (Decrease) in Prepaid Expense and Other Assets
ALPHA TEKNOVA, INC. (TKNO) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$312.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-06
- ALPHA TEKNOVA, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$155.00K, a 530.56% decline year-over-year.
- ALPHA TEKNOVA, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$157.00K, a 4025.00% decline year-over-year.
- ALPHA TEKNOVA, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$897.00K.
- ALPHA TEKNOVA, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $1.42M, a 5.01% increase year-over-year.
- ALPHA TEKNOVA, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $567.00K, a 3050.00% increase from fiscal 2024.
- ALPHA TEKNOVA, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $18.00K.
- ALPHA TEKNOVA, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$131.00K.
- ALPHA TEKNOVA, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$64.00K, a 104.92% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$155.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$312.00K 10-Q · filed 2026-08-06 | -$1.21M derived: sum of 3 quarters · filed 2026-08-06 | $215.00K derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | -$157.00K 10-Q · filed 2026-05-07 | -$1.05M derived: sum of 2 quarters · filed 2026-05-07 | $370.00K derived: sum of 3 quarters · filed 2026-05-07 | $406.00K derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | -$897.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $527.00K derived: sum of 2 quarters · filed 2026-03-02 | $563.00K derived: sum of 3 quarters · filed 2026-08-06 | $567.00K 10-K · filed 2026-03-02 | |||
| 2025-09-30 | $1.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $1.46M derived: sum of 2 quarters · filed 2026-08-06 | $1.46M 10-Q · filed 2025-11-07 | $539.00K derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | $36.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $40.00K 10-Q · filed 2026-08-06 | -$885.00K derived: sum of 3 quarters · filed 2026-08-06 | $471.00K derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-03-31 | $4.00K 10-Q · filed 2026-05-07 | -$921.00K derived: sum of 2 quarters · filed 2026-05-07 | $435.00K derived: sum of 3 quarters · filed 2026-05-07 | $196.00K derived: sum of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | -$925.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $431.00K derived: sum of 2 quarters · filed 2026-03-02 | $192.00K derived: sum of 3 quarters · filed 2026-03-02 | $18.00K 10-K · filed 2026-03-02 | |||
| 2024-09-30 | $1.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $1.12M derived: sum of 2 quarters · filed 2025-11-07 | $943.00K 10-Q · filed 2025-11-07 | $118.00K derived: sum of 4 quarters · filed 2025-11-07 | |||
| 2024-06-30 | -$239.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$413.00K 10-Q · filed 2025-08-08 | -$1.24M derived: sum of 3 quarters · filed 2025-08-08 | $498.00K derived: sum of 4 quarters · filed 2025-08-08 | |||
| 2024-03-31 | -$174.00K 10-Q · filed 2025-05-09 | -$999.00K derived: sum of 2 quarters · filed 2025-05-09 | $737.00K derived: sum of 3 quarters · filed 2025-05-09 | -$34.00K derived: sum of 4 quarters · filed 2025-05-09 | |||
| 2023-12-31 | -$825.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $911.00K derived: sum of 2 quarters · filed 2025-03-07 | $140.00K derived: sum of 3 quarters · filed 2025-03-07 | -$131.00K 10-K · filed 2025-03-07 | |||
| 2023-09-30 | $1.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $965.00K derived: sum of 2 quarters · filed 2024-11-08 | $694.00K 10-Q · filed 2024-11-08 | -$453.00K derived: sum of 4 quarters · filed 2024-11-08 | |||
| 2023-06-30 | -$771.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$1.04M 10-Q · filed 2024-08-13 | -$2.19M derived: sum of 3 quarters · filed 2024-08-13 | -$369.00K derived: sum of 4 quarters · filed 2024-08-13 | |||
| 2023-03-31 | -$271.00K 10-Q · filed 2024-05-13 | -$1.42M derived: sum of 2 quarters · filed 2024-05-13 | $402.00K derived: sum of 3 quarters · filed 2024-05-13 | -$882.00K derived: sum of 4 quarters · filed 2024-05-13 | |||
| 2022-12-31 | -$1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $673.00K derived: sum of 2 quarters · filed 2024-03-27 | -$611.00K derived: sum of 3 quarters · filed 2024-03-27 | -$64.00K 10-K · filed 2024-03-27 | |||
| 2022-09-30 | $1.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $536.00K derived: sum of 2 quarters · filed 2023-11-13 | $1.08M 10-Q · filed 2023-11-13 | $607.00K derived: sum of 4 quarters · filed 2023-11-13 | |||
| 2022-06-30 | -$1.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$737.00K 10-Q · filed 2023-08-11 | -$1.21M derived: sum of 3 quarters · filed 2023-08-11 | $982.00K derived: sum of 4 quarters · filed 2023-08-11 | |||
| 2022-03-31 | $547.00K 10-Q · filed 2023-05-11 | -$547.00K 10-Q · filed 2022-05-12 | $71.00K derived: sum of 2 quarters · filed 2023-05-11 | $2.27M derived: sum of 3 quarters · filed 2023-05-11 | $1.50M derived: sum of 4 quarters · filed 2023-05-11 | ||
| 2021-12-31 | -$476.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $1.72M derived: sum of 2 quarters · filed 2023-03-30 | $953.00K derived: sum of 3 quarters · filed 2023-03-30 | $1.30M 10-K · filed 2023-03-30 | |||
| 2021-09-30 | $2.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $1.43M derived: sum of 2 quarters · filed 2022-11-14 | $1.78M 10-Q · filed 2022-11-14 | $1.57M 10-Q · filed 2021-11-12 | $803.00K derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | -$766.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$418.00K 10-Q · filed 2022-08-11 | -$175.00K 10-Q · filed 2021-08-13 | -$1.39M derived: sum of 3 quarters · filed 2022-08-11 | -$839.00K derived: sum of 4 quarters · filed 2022-08-11 | ||
| 2021-03-31 | $348.00K 10-Q · filed 2022-05-12 | -$626.00K derived: sum of 2 quarters · filed 2022-05-12 | -$73.00K derived: sum of 3 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | -$974.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | -$421.00K derived: sum of 2 quarters · filed 2022-03-18 | $949.00K 10-K · filed 2022-03-18 | ||||
| 2020-09-30 | $553.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $1.92M 10-Q · filed 2021-11-12 | |||||
| 2020-06-30 | $1.37M 10-Q · filed 2021-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |